PMCB

PharmaCyte Biotech, Inc.$0.76+0.01 (+1.45%)

Prev Close$0.75·MCap$4.8M·P/E—·Vol158.5K·Yield—

▲

Buys (12M)

$257.4K

▼

Sells (12M)

$263.9K

◆

Net Activity

Net Seller

$6.5K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at PharmaCyte Biotech, Inc. (PMCB) has been mixed between buying and selling, with 4 insider purchases totaling $257.4K and 1 insider sale totaling $263.9K. The most recent insider transaction was by SCHECHTER JONATHAN (director), who purchased $48.2K worth of shares on Jan 7, 2026. PharmaCyte Biotech, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.8M.

PMCB Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jan 7, 2026	SCHECHTER JONATHAN	director	Buy	60,000	$0.80	$48.2K0.9% OS	192,500+45%
Jan 7, 2026	Silverman Joshua	director, officer: CEO and President	Buy	100,000	$0.80	$80.5K1.5% OS	416,250+32%
Jan 5, 2026	SCHECHTER JONATHAN	Director	Buy	60,000	$0.80	$48.2K0.9% OS	0
Jan 5, 2026	Silverman Joshua	CEO and President	Buy	100,000	$0.80	$80.5K1.5% OS	0
Dec 12, 2025	Silverman Joshua	CEO and President	Sell	258,750	$1.02	$263.9K3.8% OS	0
Apr 25, 2025	SCHECHTER JONATHAN	Director	Sell	67,500	$1.02	$68.8K1.0% OS	0
Apr 25, 2025	WALKER WAYNE REMELL	Director	Sell	16,875	$1.02	$17.2K	0
Apr 25, 2025	WEINSTEIN ROBERT	Director	Sell	33,750	$1.02	$34.4K	0

PMCB Insider Buying Activity

The following table shows recent insider purchases of PharmaCyte Biotech, Inc. (PMCB) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jan 7, 2026	SCHECHTER JONATHAN	director	Buy	60,000	$0.80	$48.2K0.9% OS	192,500+45%
Jan 7, 2026	Silverman Joshua	director, officer: CEO and President	Buy	100,000	$0.80	$80.5K1.5% OS	416,250+32%
Jan 5, 2026	SCHECHTER JONATHAN	Director	Buy	60,000	$0.80	$48.2K0.9% OS	0
Jan 5, 2026	Silverman Joshua	CEO and President	Buy	100,000	$0.80	$80.5K1.5% OS	0

PMCB Insider Selling Activity

The following table shows recent insider sales of PharmaCyte Biotech, Inc. (PMCB) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Dec 12, 2025	Silverman Joshua	CEO and President	Sell	258,750	$1.02	$263.9K3.8% OS
Apr 25, 2025	SCHECHTER JONATHAN	Director	Sell	67,500	$1.02	$68.8K1.0% OS
Apr 25, 2025	WALKER WAYNE REMELL	Director	Sell	16,875	$1.02	$17.2K
Apr 25, 2025	WEINSTEIN ROBERT	Director	Sell	33,750	$1.02	$34.4K